In our previous study, we showed altered expression and significant increase of α2,3-linked sialylated proteins in ovarian cancer patients and the enhanced α2,3-linked sialylation was directly linked to increased expression of ST3GalI [16]. This evidence concerns the gene ST3GAL1 and ovarian carcinoma.